Antineoplastic drugs in healthcare settings: Occupational exposure and risk graduation
Antineoplastic drugs (ADs) are hazardous medicinal products highlighted in the EU strategic framework on health and safety at work 2021–2027. To minimize workers' chronic exposure in oncologic settings, regular monitoring programs for these drugs are crucial and mandatory in the EU (Directive 2...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2025-01-01
|
Series: | Emerging Contaminants |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405665024001197 |